Versameb moves forward with its lead asset towards clinical development with an Innovative synthetic doggybone DNA technology which increases quality and yield of mRNA...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the first doses of Nuvaxovid™ COVID-19 Vaccine...
Promomed Group has registered a new drug Brainmax®, reaffirming its commitment to the strategy of launching innovative, knowledge-based products. The technology developed by the...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it is expanding its mRNA pipeline with three new development...
The Pharmasyntez Group of companies is going to launch the parenteral (intravenous) nutrition department in Primorye.
At a meeting with Oleg Kozhemyako, Governor of Primorsky...
The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...